Browse 5 obviousness of patent claims cases decided by Federal Circuit. AI-powered summaries, holdings, and legal analysis.
CAFC Affirms Patent Validity for Eli Lilly's Diabetes Drug
Teva Pharmaceuticals International Gmbh v. Eli Lilly and Company, decided by Federal Circuit on April 16, 2026, resulted in a defendant win outcome. The case concerns the validity of a patent held by ...
CAFC Affirms PTAB's Non-Obviousness Finding for Adnexus Patent
Adnexus Inc. v. Meta Platforms, Inc., decided by Federal Circuit on December 5, 2025, resulted in a defendant win outcome. The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) decis...
Federal Circuit Affirms Patent Invalidity for Erectile Dysfunction Drug
Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., decided by Federal Circuit on September 23, 2025, resulted in a defendant win outcome. The core dispute involved the validity of a patent...
Federal Circuit Affirms PTAB's Non-Obviousness Finding for IGT Patents
Igt v. Zynga Inc., decided by Federal Circuit on July 22, 2025, resulted in a defendant win outcome. The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) decision that claims of IGT...
Federal Circuit Affirms PTAB Finding of Obviousness for JAK Inhibitor Patents
Incyte Corporation v. Sun Pharmaceutical Industries, Inc., decided by Federal Circuit on May 7, 2025, resulted in a defendant win outcome. The Federal Circuit affirmed the Patent Trial and Appeal Boar...
CaseLawBrief currently tracks 5 obviousness of patent claims cases from Federal Circuit. This number is updated as new opinions are published.
Outcome breakdown: Defendant Win: 5.
Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.